Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis
Ocular Immunology and Inflammation, cilt.17, sa.1, ss.56-58, 2009 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 1
- Basım Tarihi: 2009
- Doi Numarası: 10.1080/09273940802491868
- Dergi Adı: Ocular Immunology and Inflammation
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.56-58
- Anahtar Kelimeler: anti-VEGF, Behcet disease, bevacizumab, macular edema, optic disc vasculitis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Purpose: To report the efficacy of intravitreal bevacizumab injection in treatment of macular edema in a case of optic disc vasculitis. Design: Retrospective case review. Methods: A patient diagnosed with macular edema due to optic disc vasculitis was treated with intravitreal bevacizumab injection. Results: One week after injection, fundus appearance dramatically improved and macular edema regressed. The patient was followed up for 1 year after injection and there was no recurrence of macular edema. Conclusions: This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular edema in patients with optic disc vasculitis.